The anti-apoptotic PON2 protein is Wnt/β-catenin-regulated and correlates with radiotherapy resistance in OSCC patients
Authors:
Open Access
- 26 April 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (32) , 51082-51095
Abstract
The anti-apoptotic PON2 protein is Wnt/-catenin-regulated and correlates with radiotherapy resistance in OSCC patientsKeywords
This publication has 54 references indexed in Scilit:
- Oxidative stress and cancer: An overviewAgeing Research Reviews, 2013
- Protectors or Traitors: The Roles of PON2 and PON3 in Atherosclerosis and CancerJournal of Lipids, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Beyond reduction of atherosclerosis: PON2 provides apoptosis resistance and stabilizes tumor cellsCell Death & Disease, 2011
- GSK3: a multifaceted kinase in Wnt signalingTrends in Biochemical Sciences, 2010
- Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemiaBlood, 2010
- Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generationProceedings of the National Academy of Sciences, 2009
- The SWI/SNF complex and cancerOncogene, 2009
- The Wnt-dependent signaling pathways as target in oncology drug discoveryInvestigational New Drugs, 2006
- THE WNT SIGNALING PATHWAY IN DEVELOPMENT AND DISEASEAnnual Review of Cell and Developmental Biology, 2004